US pricing, Brussels assessment push new drugs out of Europe, says researcher

EU PERSPECTIVES - New medicines are reaching Europe later than the US. A recent study says two separate policies are to blame, and that the damage is the worst when they meet. Read more

Sreeram Ramagopalan, Centre for Pharmaceutical Medicine Research at King's College London / Photo: CPMR